Navigation Links
Varian Medical Systems Equips International Oncology's First Comprehensive Cancer Center in India
Date:6/16/2010

NOIDA, India, June 16 /PRNewswire-FirstCall/ -- The first in a planned series of new radiotherapy centers aimed at improving access to advanced treatments for millions of Indian cancer patients has been officially opened in Noida. Fortis International Oncology Centre, a joint initiative between International Oncology and Fortis Healthcare, is equipped with advanced radiotherapy equipment and software from Varian Medical Systems (NYSE: VAR).

Dignitaries at yesterday's official inauguration ceremony – including Dr. Montek Singh Ahluwalia, the deputy chairman of the Planning Commission of India – were given a tour of the facility to see Varian's Trilogy® medical linear accelerator in action. Trilogy, capable of delivering a full range of advanced radiotherapy and radiosurgery techniques including RapidArc® radiotherapy, has been operational at Noida for four months.

The new center is among the first in India to offer RapidArc, which enables clinicians to deliver a highly-precise image-guided intensity-modulated radiotherapy (IMRT) treatment in as little as one or two revolutions of the treatment machine around the patient, much faster than is possible with conventional IMRT. Faster treatments allow for greater precision, since there is less chance of patient or tumor movement during treatment delivery and, with less time on the treatment couch, also allow for greater patient comfort.

Pradeep K. Jaisingh, managing director and CEO of International Oncology Services Pvt Ltd, says, "There is a tremendous gap in advanced radiotherapy services in India and we are trying to fill this gap by establishing a number of dedicated oncology centers closer to the Indian population over the next two years, the first of which is here in Noida. The focus of our company is to widen availability of a US-standard of cancer care to Indian patients."

"Current radiotherapy provision in India is nowhere near sufficient for a nation of over a billion people and advanced treatments tend to only be available in the major conurbations, which means people travel large distances and are inconvenienced during treatment. By providing this oncology centre in Noida and with our second facility due to open in Mumbai in three months, we feel we can make a major difference to the treatment options for India's huge cancer population." There are fewer than 400 radiotherapy machines in India and almost half of these are outdated cobalt machines.    

Pradeep K. Jaisingh added, "Varian has technology that we believe offers our patients a superior treatment and we plan to build on our relationship with Varian going forward."

International Oncology's model is to equip, staff and run state-of-the-art oncology centers within existing hospitals. With eight such centers expected to open in India in the next two years, the group plans to follow this up by implementing a similar model in South America, South-East Asia and the Middle East in due course.

Jeff Marcus, head of Oncology Systems sales for Varian, says, "International Oncology has ambitious expansion plans and Varian is pleased to be supplying our advanced radiotherapy technology for their growing number of oncology centers."

Varian has also supplied a full suite of brachytherapy equipment and software at Fortis International Oncology Centre.

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,000 people who are located at manufacturing sites in North America, Europe, and China and approximately 79 sales and support offices around the world. For more information, visit http://www.varian.com.


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , January 19, 2017 ... administration appears serious about reducing the FDA,s regulatory ... innovation in the medical drug industry, many of ... with new clinical trials and development of advanced ... forging ahead with recent developments include:  Moleculin Biotech, ...
(Date:1/19/2017)... 2017  ViewRay, Inc. (Nasdaq: VRAY ... clinical MRI-guided radiation therapy system, announced today that it ... million through a private placement of its common ... financing and was joined by certain of ViewRay,s ... Venture Partners, and an additional new institutional investor, ...
(Date:1/19/2017)... ROCKVILLE, Md. , Jan. 18, 2017 /PRNewswire/ ... a late-stage clinical company developing therapeutics designed to ... health of patients, today confirmed plans to initiate ... the Company,s modified-release reformulation of lovastatin lactone designed ... M. smithii) in the gut to treat ...
Breaking Medicine Technology:
(Date:1/19/2017)... San Francisco, CA (PRWEB) , ... January 19, 2017 , ... ... and financial planning assistance to commercial and residential clients in the California Bay Area, ... promote positive heart health in the region. , Heart disease is the primary killer ...
(Date:1/19/2017)... ... 19, 2017 , ... Attorney Robert “RC” Pate , founder of The ... the Triumph Over Kid Cancer foundation. Each year, 175,000 children are diagnosed with pediatric ... firsthand the effect of the critical funding gap for research into pediatric cancer research. ...
(Date:1/19/2017)... , ... January 19, 2017 , ... Connecticut Dermatology Group ... Kim, a highly experienced and compassionate dermatologist. Dr. Kim brings an extensive background ... , “It is with considerable pleasure to welcome back Dr. Kim to the CDG ...
(Date:1/19/2017)... ... 19, 2017 , ... Each year, the Southeastern Society of ... hundreds of surgeons from over fifteen different countries come together to share and ... augmentation to breast reconstruction for breast cancer patients, teaching these surgical techniques ...
(Date:1/18/2017)... ... 2017 , ... From a health perspective, 2017 will clearly be the Year ... chronic disease, mental health and general physical well-being. The New York Times suggested a ... , For one Charlottesville restaurant, good gut health is clearly on the menu. ...
Breaking Medicine News(10 mins):